EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Steroid-Refractory Acute GVHD: Predictors and Outcomes

Jason R Westin, Rima M Saliba, Marcos De Lima, Amin Alousi, Chitra Hosing, Muzaffar H Qazilbash, Issa F Khouri, Elizabeth J Shpall, Paolo Anderlini, Gabriela Rondon, Borje S Andersson, Richard Champlin und 1 weitere

Advances in Hematology · 2011 · 2011 · 1-8

DOI: 10.1155/2011/601953 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Hematology, 2011. Verfasst von Jason R Westin und 12 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cell Transplantation & Cellular Therapy, M.D. Anderson Cancer Center, Houston, TX 77030, USA. Die Arbeit wurde bisher 179-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with steroid-resistant acute graft versus host disease (aGVHD) have a dismal prognosis, with mortality rates in excess of 90%. We sought to identify a subgroup of patients less likely to benefit from initial therapy with corticosteroids as well as the impact of response on day 14 on outcome. Retrospective evaluation was performed of patients with biopsy-proven aGVHD treated with corticosteroids after allogeneic HSCT at M.D. Anderson Cancer Center from 1998 through 2002 (). Overall response to first-line therapy on day 14 was 56%. Grade III-IV aGVHD and hyperacute GVHD were the most significant factors predicting failure. Patients who fail to respond to steroids by day 14 should be considered for clinical trials. Severity of aGVHD, hyperacute GVHD, and sex mismatch could be integrated into prognostic scoring systems which may allow for pretreatment identification of patients unlikely to benefit from standard therapy with corticosteroids.

Autor:innen und Institutionen

  • Stem Cell Transplantation & Cellular Therapy, M.D. Anderson Cancer Center, Houston, TX 77030, USA.

Zitieren

APA

Westin, J. R., Saliba, R. M., De Lima, M., Alousi, A., Hosing, C., Qazilbash, M. H., Khouri, I. F., Shpall, E. J., Anderlini, P., Rondon, G., Andersson, B. S., Champlin, R., & Couriel, D. R. (2011). Steroid-Refractory Acute GVHD: Predictors and Outcomes. Advances in Hematology, 2011, 1-8. https://doi.org/10.1155/2011/601953

Vancouver

Westin JR, Saliba RM, De Lima M, Alousi A, Hosing C, Qazilbash MH, et al. Steroid-Refractory Acute GVHD: Predictors and Outcomes. Advances in Hematology. 2011;2011:1-8. doi:10.1155/2011/601953

BibTeX
@article{Westin2011,
  author = {Westin, Jason R and Saliba, Rima M and De Lima, Marcos and Alousi, Amin and Hosing, Chitra and Qazilbash, Muzaffar H and Khouri, Issa F and Shpall, Elizabeth J and Anderlini, Paolo and Rondon, Gabriela and Andersson, Borje S and Champlin, Richard and Couriel, Daniel R},
  title = {Steroid-Refractory Acute GVHD: Predictors and Outcomes},
  journal = {Advances in Hematology},
  year = {2011},
  volume = {2011},
  pages = {1--8},
  doi = {10.1155/2011/601953}
}
Kostenlos starten →